Search research articles
Contact Us
Filters
Showing results (101-110 of 215) with videos related to
Page
of 22
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
May 2, 2013
Improved MRI quantification of spinal cord atrophy in multiple sclerosis
Hugh Kearney, Marios C Yiannakas, Khaled Abdel-Aziz, et al.
Neurology
|
October 10, 2014
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS
Carmen Tur, Sreeram Ramagopalan, Daniel R Altmann, et al.
Journal of Neurology
|
March 15, 2003
A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration
Olga Ciccarelli, David J Werring, Gareth J Barker, et al.
Brain : a Journal of Neurology
|
February 4, 2010
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis
Klaus Schmierer, Harold G Parkes, Po-Wah So, et al.
Brain : a Journal of Neurology
|
June 27, 2013
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
David Paling, Bhavana S Solanky, Frank Riemer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 15, 2015
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis
Varun Sethi, Tarek Yousry, Nils Muhlert, et al.
Annals of Neurology
|
May 6, 2003
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
Catherine M Dalton, Peter A Brex, Katherine A Miszkiel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 19, 2013
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability
David Paling, Esben Thade Petersen, Daniel J Tozer, et al.
The Lancet. Neurology
|
July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor, Julian Furby, Thomas Hayton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2010
TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis
Konstantinos Papadopoulos, Daniel J Tozer, Leonora Fisniku, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 215) with videos related to
Sort By:
Page
of 22
Journal of Magnetic Resonance Imaging : JMRI
|
May 2, 2013
Improved MRI quantification of spinal cord atrophy in multiple sclerosis
Hugh Kearney, Marios C Yiannakas, Khaled Abdel-Aziz, et al.
Neurology
|
October 10, 2014
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS
Carmen Tur, Sreeram Ramagopalan, Daniel R Altmann, et al.
Journal of Neurology
|
March 15, 2003
A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration
Olga Ciccarelli, David J Werring, Gareth J Barker, et al.
Brain : a Journal of Neurology
|
February 4, 2010
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis
Klaus Schmierer, Harold G Parkes, Po-Wah So, et al.
Brain : a Journal of Neurology
|
June 27, 2013
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
David Paling, Bhavana S Solanky, Frank Riemer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 15, 2015
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis
Varun Sethi, Tarek Yousry, Nils Muhlert, et al.
Annals of Neurology
|
May 6, 2003
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
Catherine M Dalton, Peter A Brex, Katherine A Miszkiel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 19, 2013
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability
David Paling, Esben Thade Petersen, Daniel J Tozer, et al.
The Lancet. Neurology
|
July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor, Julian Furby, Thomas Hayton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2010
TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis
Konstantinos Papadopoulos, Daniel J Tozer, Leonora Fisniku, et al.
Page
of 22